Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conjunctivitis, Allergic”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06459219
What this trial is testing

Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects

Who this might be right for
Allergic RhinitisAllergic Conjunctivitis
Sven Schneider, MD 152
Not applicableStudy completedNCT01339507
What this trial is testing

A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft

Who this might be right for
Allergic Conjunctivitis
Cunningham, Derek N., O.D., P.A. 25
Testing effectiveness (Phase 2)Study completedNCT01001091
What this trial is testing

AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

Who this might be right for
Allergic Conjunctivitis
Alcon Research 312
Not applicableLooking for participantsNCT07805759
What this trial is testing

Daydrop® Triple Action for Allergic Eye Symptoms

Who this might be right for
Allergic Conjunctivitis of Both Eyes
i+Med S.Coop. 49
Large-scale testing (Phase 3)Study completedNCT06602726
What this trial is testing

Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy

Who this might be right for
Allergic Conjunctivitis
Regeneron Pharmaceuticals 64
Not applicableNot Yet RecruitingNCT07171307
What this trial is testing

Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy

Who this might be right for
Conjunctivitis, Allergic
Instituto de Oftalmología Fundación Conde de Valenciana 60
Post-approval studies (Phase 4)Study completedNCT01534195
What this trial is testing

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Who this might be right for
Allergic Conjunctivitis
ORA, Inc. 11
Large-scale testing (Phase 3)WithdrawnNCT01657240
What this trial is testing

Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Laboratorios Sophia S.A de C.V.
Early research (Phase 1)Ended earlyNCT03038971
What this trial is testing

Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Who this might be right for
Allergic ConjunctivitisAllergic Rhinitis
Woodmont Pharmaceuticals, Inc. 2
Not applicableLooking for participantsNCT07273747
What this trial is testing

Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms

Who this might be right for
Dry Eye SymptomsAllergic Conjunctivitis of Both Eyes
Universiti Sains Malaysia 72
Large-scale testing (Phase 3)Study completedNCT02161146
What this trial is testing

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Who this might be right for
Conjunctivitis, Allergic
Allergan 240
Post-approval studies (Phase 4)Study completedNCT00357019
What this trial is testing

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Who this might be right for
Keratoconjunctivitis, Vernal
Laboratoires Thea
Post-approval studies (Phase 4)Study completedNCT01443442
What this trial is testing

Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Southern California College of Optometry at Marshall B. Ketchum University 23
Large-scale testing (Phase 3)Study completedNCT01685242
What this trial is testing

A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle

Who this might be right for
Allergic Conjunctivitis
Aciex Therapeutics, Inc. 100
Testing effectiveness (Phase 2)WithdrawnNCT00375596
What this trial is testing

The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Bausch & Lomb Incorporated
Testing effectiveness (Phase 2)Study completedNCT06293820
What this trial is testing

TL-925 For The Treatment of AC

Who this might be right for
Allergic Conjunctivitis
Telios Pharma, Inc. 80
Large-scale testing (Phase 3)Study completedNCT00244543
What this trial is testing

Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Vistakon Pharmaceuticals 110
Testing effectiveness (Phase 2)Study completedNCT03368339
What this trial is testing

Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Realm Therapeutics, Inc. 96
Not applicableNot Yet RecruitingNCT07138742
What this trial is testing

Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis

Who this might be right for
Vernal Keratoconjunctivitis
Sohag University 90
Testing effectiveness (Phase 2)WithdrawnNCT00881673
What this trial is testing

To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge

Who this might be right for
Allergic Conjunctivitis
Alcon Research
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation